Skip to main content
. 2023 Oct 4;622(7982):329–338. doi: 10.1038/s41586-023-06592-6

Extended Data Fig. 12. Mendelian randomization estimates of effect of increasing levels of PCSK9 on lipids, cardiovascular diseases and stroke risk.

Extended Data Fig. 12

(a) Effect of PCSK9 plasma protein level on lipids, cardiovascular diseases and stroke risk. (b) Comparison of PCSK9 plasma protein effect estimates based on genetic instruments from four different pQTL studies. Error bars indicate 95% confidence intervals around the effect size estimates. Sample sizes for studies from which summary statistics were derived are detailed in Supplementary Table 30.